JAMA Highlights From ESC 2024

Kirsten Bibbins-Domingo, the Editor in Chief of JAMA, dives into groundbreaking trials from the ESC 2024 Congress. She discusses the impact of antihypertensive continuation before surgery and potassium's role post-cardiac surgery. A key highlight is a triple-drug combination pill aimed at tackling resistant hypertension in Africa, showing promise in improving patient outcomes. Lastly, Bibbins-Domingo emphasizes innovative methods to manage hypertension in Nigeria, pointing to a significant leap in treatment efficacy. This conversation is a treasure trove for cardiovascular health enthusiasts.